CSL long-serving chairman and former chief executive Brian McNamee will retire next year, ending his decades-long tenure at the top of the healthcare giant, which has found itself out of favour with investors after a string of earnings downgrades and a slide in its market valuation.
McNamee, 68, once considered one of the country’s most influential corporate chairmen, will be replaced by Gordon Naylor, currently the company’s interim chief executive. CSL last week appointed British pharmaceutical executive Deborah Waterhouse , as its new chief executive.
Gift articles to anyone you choose each month when you subscribe.
